165 related articles for article (PubMed ID: 22592374)
1. Risk of fractures in patients with multiple sclerosis: a population-based cohort study.
Bazelier MT; van Staa TP; Uitdehaag BM; Cooper C; Leufkens HG; Vestergaard P; Herings RM; de Vries F
Neurology; 2012 Jun; 78(24):1967-73. PubMed ID: 22592374
[TBL] [Abstract][Full Text] [Related]
2. The risk of fracture in patients with multiple sclerosis: the UK general practice research database.
Bazelier MT; van Staa T; Uitdehaag BM; Cooper C; Leufkens HG; Vestergaard P; Bentzen J; de Vries F
J Bone Miner Res; 2011 Sep; 26(9):2271-9. PubMed ID: 21557309
[TBL] [Abstract][Full Text] [Related]
3. The risk of fracture in incident multiple sclerosis patients: the Danish National Health Registers.
Bazelier MT; Bentzen J; Vestergaard P; Stenager E; Leufkens HG; van Staa TP; de Vries F
Mult Scler; 2012 Nov; 18(11):1609-16. PubMed ID: 22472998
[TBL] [Abstract][Full Text] [Related]
4. Association between use of antidepressants or benzodiazepines and the risk of subsequent fracture among those aged 65+ in the Netherlands.
van de Ven LI; Klop C; Overbeek JA; de Vries F; Burden AM; Janssen PK
Osteoporos Int; 2018 Nov; 29(11):2477-2485. PubMed ID: 30112636
[TBL] [Abstract][Full Text] [Related]
5. A simple score for estimating the long-term risk of fracture in patients with multiple sclerosis.
Bazelier MT; van Staa TP; Uitdehaag BM; Cooper C; Leufkens HG; Vestergaard P; Bentzen J; de Vries F
Neurology; 2012 Aug; 79(9):922-8. PubMed ID: 22895583
[TBL] [Abstract][Full Text] [Related]
6. Long-term use of dipeptidyl peptidase-4 inhibitors and risk of fracture: A retrospective population-based cohort study.
Driessen JH; van den Bergh JP; van Onzenoort HA; Henry RM; Leufkens HG; de Vries F
Diabetes Obes Metab; 2017 Mar; 19(3):421-428. PubMed ID: 27943565
[TBL] [Abstract][Full Text] [Related]
7. Osteoporosis management and secondary fragility fracture rates in patients with multiple sclerosis: a matched cohort study.
Ross BJ; Ross AJ; Lee OC; Waters TL; Familia MM; Sherman WF
Osteoporos Int; 2022 Sep; 33(9):1999-2010. PubMed ID: 35670832
[TBL] [Abstract][Full Text] [Related]
8. FRAX underestimates fracture risk in patients with diabetes.
Giangregorio LM; Leslie WD; Lix LM; Johansson H; Oden A; McCloskey E; Kanis JA
J Bone Miner Res; 2012 Feb; 27(2):301-8. PubMed ID: 22052532
[TBL] [Abstract][Full Text] [Related]
9. Risk of osteoporotic fractures in multiple sclerosis patients in southwest Finland.
Åivo J; Kurki S; Sumelahti ML; Hänninen K; Ruutiainen J; Soilu-Hänninen M
Acta Neurol Scand; 2017 May; 135(5):516-521. PubMed ID: 27334254
[TBL] [Abstract][Full Text] [Related]
10. Accuracy of FRAX
Bisson EJ; Finlayson ML; Ekuma O; Marrie RA; Leslie WD
J Bone Miner Res; 2019 Jun; 34(6):1095-1100. PubMed ID: 30690793
[TBL] [Abstract][Full Text] [Related]
11. Use of thiazolidinediones and risk of osteoporotic fracture: disease or drugs?
Bazelier MT; Gallagher AM; van Staa TP; Cooper C; Leufkens HG; Vestergaard P; de Vries F
Pharmacoepidemiol Drug Saf; 2012 May; 21(5):507-14. PubMed ID: 22392882
[TBL] [Abstract][Full Text] [Related]
12. Elevated risk of clinical fractures and associated risk factors in patients with systemic lupus erythematosus versus matched controls: a population-based study in the United Kingdom.
Bultink IE; Harvey NC; Lalmohamed A; Cooper C; Lems WF; van Staa TP; de Vries F
Osteoporos Int; 2014 Apr; 25(4):1275-83. PubMed ID: 24297094
[TBL] [Abstract][Full Text] [Related]
13. Fracture rate in patients with myasthenia gravis: the general practice research database.
Pouwels S; de Boer A; Javaid MK; Hilton-Jones D; Verschuuren J; Cooper C; Leufkens HG; de Vries F
Osteoporos Int; 2013 Feb; 24(2):467-76. PubMed ID: 22531999
[TBL] [Abstract][Full Text] [Related]
14. Risk of fractures at different anatomic sites in patients with irritable bowel syndrome: a nationwide population-based cohort study.
Lee HS; Chen CY; Huang WT; Chang LJ; Chen SC; Yang HY
Arch Osteoporos; 2018 Jul; 13(1):80. PubMed ID: 30032473
[TBL] [Abstract][Full Text] [Related]
15. The association of objectively ascertained sibling fracture history with major osteoporotic fractures: a population-based cohort study.
Hamad AF; Yang S; Yan L; Leslie WD; Morin SN; Walld R; Roos LL; Lix LM
Osteoporos Int; 2021 Apr; 32(4):681-688. PubMed ID: 32935168
[TBL] [Abstract][Full Text] [Related]
16. Objectively-Verified Parental Non-Hip Major Osteoporotic Fractures and Offspring Osteoporotic Fracture Risk: A Population-Based Familial Linkage Study.
Yang S; Leslie WD; Walld R; Roos LL; Morin SN; Majumdar SR; Lix LM
J Bone Miner Res; 2017 Apr; 32(4):716-721. PubMed ID: 27859612
[TBL] [Abstract][Full Text] [Related]
17. Osteoporotic fractures and heart failure in the community.
Gerber Y; Melton LJ; Weston SA; Roger VL
Am J Med; 2011 May; 124(5):418-25. PubMed ID: 21531231
[TBL] [Abstract][Full Text] [Related]
18. All-cause mortality with current and past use of antidepressants or benzodiazepines after major osteoporotic and hip fracture.
de Bruin IJA; Klop C; Wyers CE; Overbeek JA; Geusens PPMM; van den Bergh JPW; Driessen JHM; de Vries F
Osteoporos Int; 2019 Mar; 30(3):573-581. PubMed ID: 30737577
[TBL] [Abstract][Full Text] [Related]
19. Incidence of fractures in patients with multiple sclerosis: the Danish National Health Registers.
Bazelier MT; de Vries F; Bentzen J; Vestergaard P; Leufkens HG; van Staa TP; Koch-Henriksen N
Mult Scler; 2012 May; 18(5):622-7. PubMed ID: 22020418
[TBL] [Abstract][Full Text] [Related]
20. Risk of fractures in patients with multiple sclerosis: record-linkage study.
Ramagopalan SV; Seminog O; Goldacre R; Goldacre MJ
BMC Neurol; 2012 Nov; 12():135. PubMed ID: 23126555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
